| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |